Kush Parmar, Director, 10% Owner at Entrada Therapeutics, Inc. (TRDA), sold 237,156 shares at $6.91 ($1.6M) on 2025-06-27, disclosed to the SEC on 2025-07-01.
Open-market sale of $1.6M TRDA by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.91 | 19,265 | $133K | 8.1% |
| 2 | $6.91 | 19,265 | $133K | 8.1% |
| 3 | $6.91 | 55,735 | $385K | 23.4% |
| 4 | $6.91 | 55,735 | $385K | 23.4% |
| 5 | $6.81 | 6,422 | $44K | 2.7% |
| 6 | $6.81 | 18,578 |
| $127K |
| 7.7% |
| 7 | $6.81 | 18,578 | $127K | 7.7% |
| 8 | $7.12 | 6,422 | $46K | 2.8% |
| 9 | $7.12 | 18,578 | $132K | 8.0% |
| 10 | $7.12 | 18,578 | $132K | 8.0% |
| Total | $6.93 avg | 237,156 | $1.6M | 100% |
| Filing → |
| TRDA | SELL | 2025-11-18 | $3.5M | — | Filing → |
| TRDA | SELL | 2025-07-11 | $405K | — | Filing → |
| SKYE | BUY | 2024-03-15 | $4.5M | — | Filing → |